异基因白细胞输注 allogeneic leukocyte ; ALI
同种异基因白细胞输注 allogeneic leukocyte ; ALI
供体白细胞输注 Donor leukocyte infusion
目的观察供体白细胞输注(DL I)治疗急慢性白血病和多发性骨髓瘤的疗效和安全性。
Objective To observe the therapeutic efficacy and safety of donor leukocyte infusion (DLI) in acute, chronic leukemia and multiple myeloma.
对于服用抗生素或抗真菌药物而无起色的严重的细菌或真菌感染病例通常采取白细胞输注的方法。
White cell transfusion is usually reserved for uncommon instances of severe infections with bacteria or fungi that do not respond to antibiotics or anti-fungal drugs.
结论：(1)供者白细胞的输注能使某些BMT后慢性粒细胞性白血病遗传学及血液学复发患者完全缓解。
Conclusion: (1) Donor derived leukocyte infusion can induce CML post BMT to cytogenetic and hematological CR. It has also therapeutic effects on acute leukemia relapse but is less sustained.
应用推荐